Literature DB >> 187061

En bloc removal of intrinsic neoplasms of the lacrimal gland.

J W Henderson, R W Neault.   

Abstract

The management of intrinsic neoplasms primary in the lacrimal gland is of serious concern because some of the most malignant primary tumors of the orbit occur in this glandular structure and present surgical techniques may easily disseminate the neoplasm and contribute to death or recurrences. We propose a surgical approach in which the tumor and adjacent adnexa are removed in a one-stage procedure, that is, an en bloc resection of the neoplasm, its periorbital base, and surrounding bone. This technique will minimize seeding of the tumor, provide a more complete eradication of the neoplasm without loss of the eye, and assure either a cure or a longer interval free of local recurrences or metastasis than is presently attainable.

Entities:  

Mesh:

Year:  1976        PMID: 187061     DOI: 10.1016/0002-9394(76)90068-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Prolapse of the lacrimal gland: Findings and management during blepharoplasty.

Authors:  S Castañares
Journal:  Aesthetic Plast Surg       Date:  1979-12       Impact factor: 2.326

2.  Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 3.  Epithelial tumors of the lacrimal gland: clinico-pathologic correlation and management.

Authors:  K G Riedel; A Markl; G Hasenfratz; A Kampik; F H Stefani; O E Lund
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

4.  Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.

Authors:  David T Tse; Pasquale W Benedetto; Brian C Tse; William J Feuer
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

5.  Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse; Andrea L Kossler; William J Feuer; Pasquale W Benedetto
Journal:  Ophthalmology       Date:  2013-04-09       Impact factor: 12.079

6.  Primary malignant neoplasms of the lacrimal gland.

Authors:  J E Wright; G E Rose; A Garner
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

7.  Adenocarcinoma of the lacrimal gland with sebaceous differentiation. A clinical study using light and electronmicroscopy.

Authors:  E A Konrad; H J Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

8.  Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy.

Authors:  Yun-Hsuan Lin; Shih-Ming Huang; Wing-Keen Yap; Ju-Wen Yang; Ling Yeung; Din-Li Tsan; Joseph Tung-Chieh Chang; Lung-Chien Chen
Journal:  Radiat Oncol       Date:  2020-06-22       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.